Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Verastem, Inc. (VSTM) Profit Margins

Over the twelve months to 2026-06-30, Verastem, Inc. (VSTM) had operating margin -182.6%, net margin -231.6%, free cash flow margin -185.3%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

VSTMVerastem, Inc.Follow VSTM — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
909.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
2 Nov, in 9 days
LineFY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin99.4%—————82.9%—
Operating margin-354.8%-758.1%-55.8%-2991.2%-2809.6%-1149.6%-550.3%-182.6%
Net margin-271.1%-854.8%-76.5%-3468.1%-2843.3%-1306.4%-677.6%-231.6%
FCF margin-284.5%-793.6%-37.9%-2615.6%—-1048.0%-444.8%-185.3%

USD millions · SEC XBRL

Verastem, Inc. — questions

What is Verastem, Inc.'s operating margin?
-182.6% over the twelve months to 2026-06-30.
What is Verastem, Inc.'s net profit margin?
-231.6% over the twelve months to 2026-06-30.

Every figure on this page comes from Verastem, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.